AR036177A1 - Composiciones para el tratamiento del cabello y/o del cuero cabelludo - Google Patents

Composiciones para el tratamiento del cabello y/o del cuero cabelludo

Info

Publication number
AR036177A1
AR036177A1 ARP020102691A ARP020102691A AR036177A1 AR 036177 A1 AR036177 A1 AR 036177A1 AR P020102691 A ARP020102691 A AR P020102691A AR P020102691 A ARP020102691 A AR P020102691A AR 036177 A1 AR036177 A1 AR 036177A1
Authority
AR
Argentina
Prior art keywords
compositions
hair
treatment
dandruff
leather
Prior art date
Application number
ARP020102691A
Other languages
English (en)
Inventor
Peter Lawrence Bailey
Christopher John Little
Francis Mcglone
Roman Rukwied
Allan Watkinson
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR036177(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of AR036177A1 publication Critical patent/AR036177A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las composiciones para el tratamiento del cabello y/o del cuero cabelludo comprenden un agente anti-caspa, una cantidad efectiva de un agente activador de receptor canabinoide (CBR) y un portador o diluyente cosméticamente aceptable. En forma alternativa, las composiciones pueden ser composiciones para champú que comprenden entre 3% y 50% en peso de tensioactivo, un agente activador de receptor CB y un portador o diluyente cosméticamente aceptable, siempre que el activador de receptor CB no sea palmitoil-etanolamida. Las composiciones son útiles para el tratamiento y/o la prevención de los síntomas de caspa y pueden reducir la picazón del cuero cabelludo, un síntoma que típicamente se encuentra asociado con la caspa.
ARP020102691A 2001-07-18 2002-07-18 Composiciones para el tratamiento del cabello y/o del cuero cabelludo AR036177A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01306166 2001-07-18

Publications (1)

Publication Number Publication Date
AR036177A1 true AR036177A1 (es) 2004-08-18

Family

ID=8182118

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102691A AR036177A1 (es) 2001-07-18 2002-07-18 Composiciones para el tratamiento del cabello y/o del cuero cabelludo

Country Status (9)

Country Link
US (2) US20030049220A1 (es)
EP (2) EP1406576B2 (es)
JP (2) JP2004536854A (es)
AR (1) AR036177A1 (es)
AT (1) ATE406867T1 (es)
BR (1) BR0211251B1 (es)
DE (1) DE60228713D1 (es)
ES (1) ES2312643T5 (es)
WO (1) WO2003007901A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60038979D1 (de) * 1999-12-28 2008-07-03 Teikoku Seiyaku Kk Wirkstoffe gegen pruritus zum äusserlichen gebrauch
JP2007191495A (ja) * 2001-10-22 2007-08-02 Santen Pharmaceut Co Ltd 掻痒治療剤
PT1477186E (pt) * 2002-02-19 2010-02-11 Shionogi & Co Antipruriginosos
TW200843761A (en) 2004-10-28 2008-11-16 Shionogi & Co 3-carbamoyl-2-pyridone derivatives
FR2879443B1 (fr) * 2004-12-21 2007-07-13 Jean Noel Thorel Utilisation d'une base nutritive complexe dans le domaine cosmetique, en particulier capillaire
MX2007011142A (es) 2005-03-12 2007-11-06 Unilever Nv Composiciones para el cuidado del cabello y/o cuero cabelludo que incorporan compuestos de amino-oxo-indol-ilideno.
EP2082726A3 (en) * 2005-03-12 2009-09-02 Unilever PLC Hair and/or scalp care compositions incorporating flavonoid compounds
US20080255082A1 (en) * 2005-03-12 2008-10-16 Ranjit Bhogal Hair and/or Scalp Care Compositions Incorporating Terpenoid Compounds
BRPI0607967B1 (pt) * 2005-03-12 2022-07-19 Unilever Ip Holdings B.V Uso de visnadina
BRPI0713209A2 (pt) 2006-07-07 2012-03-20 Unilever N.V composição de condicionamento de cabelos e método de mitigar caspa
JP2011505398A (ja) 2007-12-06 2011-02-24 ユニリーバー・ナームローゼ・ベンノートシヤープ 身体手入れ組成物
EP2214630A1 (en) * 2007-12-06 2010-08-11 Unilever PLC Personal care composition
US9623000B2 (en) * 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
EP2174642A1 (en) * 2008-10-10 2010-04-14 Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House Use of Personal Care Composition
CN102481238A (zh) * 2009-05-08 2012-05-30 荷兰联合利华有限公司 组合物
JP5615515B2 (ja) * 2009-05-26 2014-10-29 持田製薬株式会社 洗浄用組成物
FR2965477A1 (fr) * 2010-10-05 2012-04-06 Oreal Utilisation de cannabidiol contre les desequilibres de la microflore cutanee
US8758826B2 (en) 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
US8425950B1 (en) 2011-11-29 2013-04-23 Victor M. Santillan Liquid mixture and methods for use
WO2014059008A1 (en) 2012-10-09 2014-04-17 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
WO2014059009A1 (en) 2012-10-09 2014-04-17 The Procter & Gamble Company Method of identifying synergistic cosmetic combinations
JP6195840B2 (ja) 2012-10-22 2017-09-13 ユニバーサル・バイオ・リサーチ株式会社 複数種の目的物質を同時に検出又は定量するための分析方法及び分析キット
JP6461000B2 (ja) 2012-12-14 2019-01-30 ザ プロクター アンド ギャンブル カンパニー 芳香材料
EP2934138A1 (en) * 2012-12-21 2015-10-28 Arch Personal Care Products, Lp Cationic pyrithione dispersion
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
FR3007273B1 (fr) * 2013-06-21 2015-07-31 Oreal Utilisation cosmetique d'un plasma froid
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
ES2731729T3 (es) * 2014-05-14 2019-11-18 Epitech Group S P A Uso de palmitoiletanolamida en combinación con opioides
EP3673738B1 (en) 2015-05-20 2024-02-28 Apeel Technology, Inc. Plant extract compositions and methods of preparation thereof
CN108135188B (zh) 2015-09-16 2022-08-05 阿比尔技术公司 用于分子涂层的前体化合物
WO2017100636A1 (en) 2015-12-10 2017-06-15 Apeel Technology, Inc. Plant extract compositions for forming protective coatings
WO2017132281A1 (en) 2016-01-26 2017-08-03 Apeel Technology, Inc. Method for preparing and preserving sanitized products
WO2018094269A1 (en) 2016-11-17 2018-05-24 Apeel Technology, Inc. Compositions formed from plant extracts and methods of preparation thereof
WO2018148785A1 (en) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
WO2018148786A1 (en) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of acne
WO2018148787A1 (en) * 2017-02-15 2018-08-23 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of psoriasis
EP3582770A4 (en) * 2017-02-15 2020-11-18 Botanix Pharmaceuticals Ltd CANNABINOID FORMULATIONS FOR THE TREATMENT OF ACNE
BR112019017018A2 (pt) * 2017-02-15 2020-04-14 Botanix Pharmaceuticals Ltd formulações de canabinoides para o tratamento de dermatite e doenças de pele inflamatórias
US10143639B2 (en) * 2017-03-22 2018-12-04 William Robert McDaniel Use of adelmidrol and other topical or oral cannabinomimetic or aliamide mast cell inhibitors to treat dermatoheliosis, seborrheic keratoses, and androgenetic alopecia
EP3743054A4 (en) 2018-01-24 2021-11-10 Botanix Pharmaceuticals Ltd CANNABINOID DOSING SCHEME FOR DERMATITIS AND INFLAMMATORY SKIN DISEASES
US12245605B2 (en) 2018-09-05 2025-03-11 Apeel Technology, Inc. Compounds and formulations for protective coatings
US11641865B2 (en) 2020-03-04 2023-05-09 Apeel Technology, Inc. Compounds and formulations for protective coatings
MX2023004343A (es) 2020-10-30 2023-05-08 Apeel Tech Inc Composiciones y metodos de preparacion de las mismas.
WO2023274774A1 (en) 2021-07-01 2023-01-05 Unilever Ip Holdings B.V. Hair care composition
EP4398731A1 (en) 2021-09-08 2024-07-17 Apeel Technology, Inc. Compounds and formulations for protective coatings

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773835A (en) * 1951-11-16 1956-12-11 Colgate Palmolive Co Liquid shampoo composition
DE1669152A1 (de) * 1967-07-07 1970-12-03 Hoechst Ag Perlglanzbildner zum Eintrueben von fluessigen oder pastoesen Praeparaten
US4722837A (en) * 1984-05-29 1988-02-02 Derma-Cure, Inc. Medicated shampoo composition
DE3519080A1 (de) * 1985-05-28 1986-12-04 Henkel Kgaa Fliessfaehiges perlglanzkonzentrat
US5154847A (en) † 1986-06-16 1992-10-13 Helene Curtis, Inc. Antidandruff shampoo composition having improved suspension properties
JPH06503085A (ja) * 1990-12-19 1994-04-07 ビーチャム・グループ・パブリック・リミテッド・カンパニー 新規組成物
FR2685638A1 (fr) † 1991-12-31 1993-07-02 Biorga Sa Laboratoires Compositions pour l'usage cosmetique et/ou dermatologique, comprenant une association de pyrithione zinc, de piroctone olamine, et d'un derive de collagene et d'acide gras.
IT1257697B (it) † 1992-04-24 1996-02-01 Lifegroup Spa N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
US5679667A (en) * 1992-04-24 1997-10-21 Lifegroup S.P.A. Aminoalcohols-N-Acyl derivatives as therapeutical agents against the neurogenic endoneural edema of the peripheral nerve
US5641480A (en) * 1994-12-08 1997-06-24 Lever Brothers Company, Division Of Conopco, Inc. Hair care compositions comprising heteroatom containing alkyl aldonamide compounds
IT1271266B (it) * 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
FR2735774B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
CZ293585B6 (cs) † 1996-02-16 2004-06-16 Janssen Pharmaceutica N. V. Tělový a vlasový čisticí přípravek a způsob přípravy tohoto přípravku
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5730965A (en) † 1996-06-13 1998-03-24 Dermatology Home Products, Inc. Shampoo for treating seborrheic dermatitis, dandruff or psoriasis
GB2338413B (en) † 1998-06-18 2003-09-24 Gursharan Singh Moonga Topical and transdermal delivery by multi-micro dilution (MMD) technology
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
IT1302264B1 (it) * 1998-09-24 2000-09-05 Innovet Italia Srl Derivati a struttura n-acil vanillinamidica in grado di attivare irecettori periferici dei cannabinoidi
JP2002528566A (ja) † 1998-10-26 2002-09-03 フイルメニツヒ ソシエテ アノニム 抗菌性香料組成物
WO2001004083A1 (en) * 1999-07-07 2001-01-18 Innovet Italia S.R.L. Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor
WO2001010434A1 (en) † 1999-08-06 2001-02-15 Innovet Italia S.R.L. Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field
GB9923738D0 (en) * 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
WO2001085158A2 (en) * 2000-05-08 2001-11-15 Forskarpatent I Syd Ab Anandamide and structurally related lipids as vanilloid receptor modulators
US20020077322A1 (en) * 2000-12-15 2002-06-20 Ayoub George S. Protection of neurons against glutamate-induced damage in glaucoma and other conditions

Also Published As

Publication number Publication date
ES2312643T5 (es) 2011-10-18
WO2003007901A1 (en) 2003-01-30
ATE406867T1 (de) 2008-09-15
US20100029778A1 (en) 2010-02-04
EP1406576B1 (en) 2008-09-03
EP1406576A1 (en) 2004-04-14
JP2007145858A (ja) 2007-06-14
BR0211251B1 (pt) 2013-09-17
US20030049220A1 (en) 2003-03-13
ES2312643T3 (es) 2009-03-01
BR0211251A (pt) 2004-07-27
DE60228713D1 (de) 2008-10-16
JP2004536854A (ja) 2004-12-09
EP1406576B2 (en) 2011-06-29
EP1785130A3 (en) 2007-11-28
EP1785130A2 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
AR036177A1 (es) Composiciones para el tratamiento del cabello y/o del cuero cabelludo
AR009643A1 (es) Composiciones antimicrobianas para el cuidado personal
ES2182837T3 (es) Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
ES2110747T3 (es) Composicion cosmetica que contiene precursores de ceramida.
MX172076B (es) Composicion de enriquecimiento para el cabello
ES2147538B1 (es) Una locion capilar con propiedades mejoradas en su accion protectora del cabello y preventiva de su caida, y de reduccion de los efectos externos de la alopecia androgenetica y con ello de la caida del cabello.
ES2188147T3 (es) Anti-irritantes en composiciones cosmeticas.
KR910009238A (ko) 자외선차단제 조성물
DE50014447D1 (de) Tablettierung verdickender systeme
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
ES2178263T3 (es) Composiciones oftarmologicas que contienen un glicosido cationico y unagente terapeutico anionico.
AR248032A1 (es) Procedimiento para la produccion de polipropilenos bajo alta presion.
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
AR041619A1 (es) Una composicion para la aplicacion topica al cuero cabelludo
FR2774900B1 (fr) Shampoings antipelliculaires transparents
DE69720542D1 (de) PYRIDOCARBAZOL DERIVATE DIE EINEN cGMP-PDE INHIBILIERENDEN EFFEKT HABEN
ES2075359T3 (es) Composicion de cosmetico para el cabello.
ES2144620T3 (es) Mezclas fungicidas de dos y tres componentes.
DE69521037D1 (de) Chinazolinylamino derivate mit alfa-antagonist wirkung
AR003889A1 (es) Una composición depilatoria y el uso de agentes tixotrópico.
FR2742048B1 (fr) Utilisation de l'alpha-cyano-beta, beta-diphenylacrylate de 2-ethylhexyle pour ameliorer la stabilite de compositions cosmetiques contenant le p-methyl-benzylidene camphre en association avec un derive de dibenzoylmethane
PE33199A1 (es) Composiciones de tinte para el pelo
IT1255668B (it) Agenti ausiliari per operazioni di tintura e loro impiego
AR036899A1 (es) Composiciones cosmeticas

Legal Events

Date Code Title Description
FB Suspension of granting procedure